Study on cervical cancer with limited spread
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at patients whose cervical cancer has come back or spread to a few spots (oligo-metastasis or oligo-recurrence). It aims to learn how well different treatments, including radiation, work for these patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cervical cancer that has spread to a few places (not widespread) or come back in a few spots.
- You may have had treatment for this before, including radiation or other therapies.
- If the cancer was widespread but responded well to chemotherapy, you can join if the remaining spots were treated with radiation.
- You can also join if you have been treated with other local treatments like surgery or ablation.
- You cannot have other types of gynecological cancer, and you must have follow-up after treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at women with cervical cancer that has spread to only a few places (oligo-metastatic) or come back in a few places (oligo-recurrent). It hopes to understand how well treating those spots with radiation or other local treatments works, even if you've already had treatment before.
This study is for people with solid tumors that have spread to a few spots (5 or fewer) in the body. It tests whether using a focused treatment like radiation or ablation on those spots can help control the cancer long-term.
This trial tests whether treating just the few spots where breast cancer has spread (called oligometastases) with radiation or surgery can help control the disease. It is for people whose cancer has spread to 3 or fewer places, each small in size, and who are healthy enough for local treatments.
This trial tests whether using local treatments (like targeted radiation or ablation) on a few new spots of cancer can help people whose cancer is otherwise stable on their current treatment. It enrolls people with various solid tumors, such as breast, gynecologic, head & neck, sarcoma, or other types.
This observational study follows people with rare solid tumors and a limited number of metastases treated with a focused radiation technique (SBRT). Doctors want to see outcomes after using a strong, curative-intent radiation dose to all active spots.
This trial tests a new immunotherapy drug (cadonilimab) combined with standard chemoradiation for cervical cancer that has spread to a few other places in the body. It aims to see if this combination can help control the cancer better.
Hear when a new Recurrence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.